ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC

ABVC BIOPHARMA, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$0.91−0.01 (-0.86%)

Close on Oct 19, 2026

Market cap: $23.71M
P/E (TTM): –
Dividend yield: –

ABVC BIOPHARMA, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2017 2017-09-30	FY 2016 2016-09-30	FY 2015 2015-09-30	FY 2014 2014-09-18	FY 2013 2013-09-30	FY 2012 2012-09-30	FY 2011 2011-09-30	FY 2010 2010-09-30
Cash & Equivalents	0.68	0.86	0.72	1.39	6.57	5.00	0.16	0.20	0.17	0.99	–	0.00	0.01	0.07	0.00
Short-Term Investments	0.06	0.06	0.08	0.08	0.11	–	–	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	0.75	0.93	0.80	1.47	6.67	5.00	0.16	0.20	0.17	0.99	–	0.00	0.01	0.07	0.00
Receivables	–	–	0.84	0.10	0.28	0.16	0.16	–	–	–	–	0	0	–	–
Inventory	–	–	–	–	0.03	–	–	–	–	0.00	–	0.00	–	–	–
Prepaid Expenses & Other	0.35	0.10	0.10	0.15	0.53	0.17	0.08	–	–	0.00	–	0	0.03	0.03	0.03
Total Current Assets	2.50	2.18	1.66	2.99	7.65	6.17	0.88	2.75	0.17	1.00	–	0	0.05	0.10	0.03
Property, Plant & Equipment	13	0.51	0.57	0.57	0.53	0.51	0.52	–	–	0	–	0	0.05	0.06	0.04
Gross Property, Plant & Equipment	16	3.85	3.90	3.88	3.84	3.81	3.76	–	–	–	–	–	–	0.15	0.12
Accumulated Depreciation	-3.38	-3.34	-3.34	-3.30	-3.31	-3.30	-3.24	–	–	–	–	–	–	-0.09	0.07
Construction in Progress	–	–	0.57	–	–	–	–	–	–	–	–	–	–	–	–
Long-Term Investments	1.88	2.26	2.53	0.84	0.93	1.19	3.36	–	–	–	–	–	–	–	–
Equity Method Investments	-0.19	-0.34	-0.22	0.84	0.93	1.19	3.36	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	1.91	0.64	0.81	1.16	1.47	1.77	0.52	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	–	–	–	–	0.06	–	0.06	0.21	0.21	–
Deferred Tax Assets	–	–	–	0.12	0.98	1.79	1.46	–	–	–	–	–	–	–	–
Other Long-Term Assets	0.12	0.13	0.14	–	–	–	–	–	–	–	–	–	–	–	–
Total Assets	21	7.54	7.78	9.58	14	12	6.93	2.75	0.18	1.00	–	0.06	0.30	0.37	0.29
Accounts Payable	–	–	–	–	–	0.02	0.02	–	–	0.02	–	0.16	0.08	0.25	0.99
Accrued Expenses	–	–	3.70	2.91	1.30	2.12	–	–	–	0.02	–	0.02	–	0.22	0.07
Short-Term Debt	0.76	0.84	0.90	1.89	1.64	1.63	1.92	–	–	–	–	–	–	–	–
Current Debt	0.76	0.84	0.90	1.89	1.64	1.63	1.92	–	–	–	–	–	–	–	–
Current Portion of Leases	0.32	0.40	0.40	0.37	0.35	0.32	0.30	–	–	–	–	–	–	–	–
Current Income Taxes Payable	0.01	–	0.11	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	0.01	0.08	0.08	0.01	–	–	–	–	–	–	–	–	–	–	–
Other Current Liabilities	–	0.77	0.17	0.36	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	6.16	6.56	6.10	5.54	3.69	4.84	6.81	–	–	0.04	–	0.03	1.95	1.83	3.29
Long-Term Leases	1.60	0.24	0.41	0.79	1.12	1.46	0.24	–	–	–	–	–	–	–	–
Operating Lease Liabilities	1.92	0.64	0.81	0.21	0.35	0.32	0.54	–	–	–	–	–	–	–	–
Total Liabilities	7.76	6.82	6.53	6.34	4.83	8.94	7.05	4.15	6.56	0.37	–	0.03	1.95	1.83	3.29
Total Debt	0.76	0.84	0.90	1.89	1.64	1.63	1.92	–	–	–	–	–	–	–	–
Preferred Stock	–	–	–	–	–	–	–	–	–	–	–	0.00	0.00	0.00	0.00
Common Stock	0.03	0.01	0.01	0.00	0.03	0.02	0.02	0.21	0.21	0.17	–	0.05	0.05	0.01	0.03
Additional Paid-In Capital	96	79	74	68	58	41	28	14	4.73	1.13	–	0	29	27	23
Retained Earnings	-77	-69	-64	-55	-38	-26	-16	-15	-11	-0.32	–	-0.02	-30	-29	-26
Treasury Stock	-8.91	-8.91	-8.90	-9.10	-9.10	-9.10	-9.10	–	–	–	–	–	–	–	–
Comprehensive Income & Other	0.49	0.45	0.52	0.52	0.54	0.56	–	–	–	–	–	–	–	–	–
Shareholders' Equity	11	1.23	1.55	3.10	8.84	3.44	-0.15	-1.39	-6.38	0.63	0.05	0.03	-1.64	-1.46	-2.99
Noncontrolling Interest	2.19	-0.50	-0.30	0.14	0.03	-0.78	0.03	–	–	–	–	–	–	–	–
Total Equity	13	0.72	1.25	3.24	8.87	2.66	-0.12	-1.39	-6.38	0.63	0.05	0.03	-1.64	-1.46	-2.99
Total Liabilities & Equity	21	7.54	7.78	9.58	14	12	6.93	2.75	0.18	1.00	–	0.06	0.30	0.37	0.29
Shares Outstanding(shares)	25	14	7.94	3.29	2.44	2.44	1.95	1.16	1.14	0.90	–	15	3.98	3.98	0.18

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: -2201.1%
Net margin: -2400.9%
Return on equity, FY2025: -128.2%

Financial strength

Current ratio: 0.07
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.6%

Valuation

P/E ratio: –
Price to sales: 80.11
Price to book: 2.31
Dividend yield: –